Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patients

Journal of Cardiovascular Risk

Volumn 6, Issue 5, 1999, Pages 327-331

  Bruckert, Eric ^a   Giral, Philippe ^a   Chadarevian, Rita ^a   Turpin, Gérard ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Atherosclerosis; Free thyroxine; Risk factor; Thyroid hormones; Thyroxine

Indexed keywords

CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROID HORMONE; THYROXINE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE; THYROTROPIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERIOGRAPHY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THYROID HORMONE BLOOD LEVEL; AGE; BODY MASS; BODY WEIGHT; CAROTID ATHEROSCLEROSIS; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPERTENSION; SMOKING; SYSTOLIC BLOOD PRESSURE; THYROID DISEASE;

EID: 0033384767     PISSN: 13506277     EISSN: None     Source Type: Journal    
DOI: 10.1177/204748739900600510     Document Type: Article

References (42)

1. Gomberg-Maitland M, Frishman W. Thyroid hormone and cardiovascular disease. Am Heart J 1998; 135:187-196.
2. Powell J, Zadeh JA, Carter G, Greenhalgh RM, Fowler PBS. Raised serum thyrotropin in women with peripheral arterial disease. Br J Surg 1987; 74:1139-1141.
3. Green WL, Hazzard WR, Hershman JM. Thyrotropin levels in hyperlipidemic survivors of myocardial infarction. Metabolism 1976; 25:465-470.
4. Perk M, O'Neill BJ. The effect of thyroid hormone therapy on angiographic coronary artery disease progression. Can J Cardiol 1997; 13:273-276.
5. Klein I, Levey GS. The cardiovascular system in thyroxicosis. In: Braverman LF, Utiger RD (editors): Warner and Inbars's The Thyroid. Philadelphia: Lippincott-Raven Publishers; 1996. pp. 607-615.
6. Krasner LJ, Wendling WW, Cooper SC, Chen D, Hellmann SK, Eldridge CJ, et al. Direct effects of triodothyronine on human internal mammary artery and saphenous veins. J Cardiothorac Vasc Anesth 1997; 11:463-466.
7. Polikar R. Burger AG. Scherrer U. Nicod P. The thyroid and the heart. Circulation 1993; 87:1435-1441.
8. Chait A, Bierman EL, Albers J. Regulatory role of T3 in the degradation of LDL by cultured human skin fibroblast. J Clin Endocrinol Metab 1979; 48:887-889.
9. Valdemarsson S, Hender P, Nilsson-Ehle P. Treatment of hyperthyroidism: Effect on hepatic lipase, lipoprotein lipase, LCAT and plasma lipoproteins. Scand J Clin Lab Invest 1984; 44:183-189.
10. Staels B, van Tol A, Chan L, Will H, Verhoeven G, Auwerx J. Alterations in thyroid status modulate apolipoprotein. Hepatic triglyceride lipase and low density lipoprotein receptor in rats. Endocrinology 1990; 127:1144-1152.
11. Packard CJ, Shepherd J, Lindsay GM, Gaw A, Taskinen MR. Thyroid replacement therapy and its influence on postheparin plasma lipases and apolipoprotein B metabolism in hypothyroidism. J Clin Endocrinol Metab 1993; 76:1209-1216.
12. Farid NR, Griffiths BL, Collins JR, Marshall WH, Ingram DW. Blood coagulation and fibrinolysis in thyroid disease. Thromb Haemost 1976; 35:415-422.
13. Dalton RG, Savidge GF, Matthews KB, Dewar MS, Kernoff PBA, Greaves M, et al. Hypothyroidism as a cause of acquired Von Willebrand's disease. Lancet 1987; 1;1007-1009.
14. Palareti G, Biagi G, Legnani C, Bianchi D, Serra D, Savini R, et al. Association of reduced factor VIII with impaired platelet reactivity to adrenalin and collagen after total thyroideclomy. Thromb Haemost 1989; 62:1053-1056.
15. Myrup B, Bregengard C, Faber JF. Primary haemostasis in thyroid disease. J Intern Med 1995; 238:59-63.
16. Hofbauer LC, Heufelder AE, Coagulation disorders in thyroid diseases. Eur J Endocrinol 1997; 136:1-7.
17. Chadarevian R, Bruckert E, Ankri A, Beucler I, Giral P, Turpin G. Relationship between thyroid hormones and plasma D-dimer levels. Thromb Haemost 1998; 79:99-103.
18. Nieuwenhuizen W. Biochemistry and measurement of fibrinogen. Eur Heart J 1995; 16 (suppl A):6-10.
19. Salonen R, Seppänen K, Rauramaa R, Salonen J. Prevalence of carotid atheroscleresis and serum cholesterol levels in eastern Finland. Arteriosclerosis 1988; 8:788-792.
20. Bruckert E, Giral P, Kahn JF, Salloum J, Dairou F, Truffert J, et al. Carotid stenosis is a powerful predictor of a positive exercise electrocardiogram in a large hyperlipidemic population. Atherosclerosis 1992; 92;105-114.
21. Goldman MB, Monson RR, Maloof F. Cancer mortality in women with thyroid disease. Cancer Res 1990; 50:2283-2289.
22. Staub JJ, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, et al. Spectrum of subclinical and overt hypothyroidism: Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissue. Am J Med 1992; 92:631-642.
23. Becker C. Hypothyroidism and atherosclerotic heart disease: Pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocrinol Rev 1985; 6:432-440.
24. Kinlaw WB. Thyroid disorders and cholesterol: Identifying the realm of clinical relevance. Endocrinologist 1995; 5:148-155.
25. Costantini F, Pierdomenico SD, De Cesare D, De Remigis P, Bucciarelli T, Bittolo-Bon G, et al. Effect of thyroid function on LDL oxidation. Arterioscler Thromb Vasc Biol 1998; 18:732-737.
26. Sundaram V, Hanna AN, Koneru L, Newman HAI, Falko JM. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab 1997; 82:3421-3424.
27. Benvenga S, Cahnmann HJ, Robbisn J. Localisation of the thyroxine binding sites in apolipoprotein B-100 of human low density lipoproteins. Endocrinology 1990; 127:2241-2246.
28. Althaus BU, Staub JJ, Ryff-de Léche A, Oberhansli A, Stähelin HB. LDL/HDL changes in subclinical hypothyroidism: Possible risk factors for coronary heart disease. Clin Endocrinol 1988; 28:157-163.
29. Lowe GDO, Fowkes FGR, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh artery study. Circulation 1993; 87:1915-1920.
30. Sweetnam PM, Thomas HF, Yarnell JWG, Beswick AD, Baker IA, Elwood PC. Fibrinogen, viscosity, and the ten year incidence of ischaemic heart disease. The Caerphilly and Speedwell studies. Eur Heart J 1996; 17:1814-1820.
31. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med 1993; 118:956-963.
32. Heinrich J, Balleisen L, Schulte H, Assmann G, Van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14:54-59.
33. Levenson J, Giral P, Razavian M, Gariepy J, Simon A. Fibrinogen and silent atherosclerosis in subjects with cardio-vascular risk factors. Arterioscler Thromb Vasc Biol 1995; 15:1263-1268.
34. Bastenie PA, Vanhaelst L, Goldstein J, Smets Ph, Keys A, Karvonen MJ, et el. Asymptomatic autoimmune thyroiditis and coronary heart-disease. Cross-sectional and prospective studies. Lancet 1977; ii:155-158.
35. Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocrinol Rev 1993; 14:107-120.
36. Xu Q, Dietrich H, Steiner HJ, Gown AM, Schoel B, Mikuz G, et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 1992; 12:789-799.
37. Mooradian AD. Normal age-related changes in thyroid hormone economy. Clin Geriatr Med 1995; 11:159-169.
38. Kabadi UM, Rosman PM. Thyroid hormone indices in adult healthy subjects: No influence of aging. J Am Geriatr Soc 1998; 36:312-316.
39. Faldr R, Passant U, Nilsson K, Wattmo C, Gustafson L. Prevalence of thyroid hormone abnormalities in elderly patients with symptoms of organic brain disease. Aging 1996; 8:347-353.
40. Ericsson UB, Lindgärde F. Effects of cigarette smoking on thyroid function and the prevalence of goitre, thyrotoxicosis and autoimmune thyroiditis. J Intern Med 1991; 229:67-71.
41. Melander A, Nordenskjold E, Lundh B, Thorell J. Influence of smoking on thyroid activity. Acta Med Scand 1981; 209:41-43.
42. Muller B, Zulewski H, Huber P, Ratcliffe JG, Staub JJ. Impaired action of thyroid hormone associated with smoking in women with hypothyroidism. N Engl J Med 1995; 333:964-969.